AAV Mediated Expression of Activated Factor V (FVa) for Hemophilia

被引：0
|
作者：
Sun, Junjiang [1 ,2 ]
Chai, Zheng [1 ]
Chen, Xiaojin [1 ]
Ralph, Taylor [1 ]
Nichols, Timothy C. [3 ]
Li, Chengwen [1 ]
机构：
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
943
引用
收藏
页码：410 / 411
页数：2
相关论文
共 50 条
  • [1] Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correction
    Sun, Junjiang
    Chen, Xiaojing
    Chai, Zheng
    Niu, Hongqian
    Dobbins, Amanda L. L.
    Nichols, Timothy C. C.
    Li, Chengwen
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
    George, Lindsey A.
    Monahan, Paul E.
    Eyster, M. Elaine
    Sullivan, Spencer K.
    Ragni, Margaret, V
    Croteau, Stacy E.
    Rasko, John E. J.
    Recht, Michael
    Samelson-Jones, Benjamin J.
    MacDougall, Amy
    Jaworski, Kristen
    Noble, Robert
    Curran, Marla
    Kuranda, Klaudia
    Mingozzi, Federico
    Chang, Tiffany
    Reape, Kathleen Z.
    Anguela, Xavier M.
    High, Katherine A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21): : 1961 - 1973
  • [3] Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
    Wang, LL
    Nichols, TC
    Read, MS
    Bellinger, DA
    Verma, IM
    MOLECULAR THERAPY, 2000, 1 (02) : 154 - 158
  • [4] AAV-mediated gene transfer for hemophilia
    High, KA
    NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS, 2001, 953 : 64 - 74
  • [5] AAV-mediated gene transfer for hemophilia
    High, K
    GENETICS IN MEDICINE, 2002, 4 (06) : 56S - 61S
  • [6] AAV-mediated gene therapy for hemophilia
    Couto, LB
    Pierce, GF
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (05) : 517 - 523
  • [7] Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B
    Jiang, Haiyan
    Pierce, Glenn F.
    Ozelo, Margareth C.
    de Paula, Erich V.
    Vargas, Joseph A.
    Smith, Peter
    Summer, Juerg
    Luk, Alvin
    Manno, Catherine S.
    High, Katherine A.
    Arruda, Valder R.
    MOLECULAR THERAPY, 2006, 14 (03) : 452 - 455
  • [8] Modulation of the expression of hemophilia phenotype by factor V Leiden.
    Richardson, LC
    Lally, C
    Walton, K
    Evatt, BL
    BLOOD, 1999, 94 (10) : 91B - 91B
  • [9] Factor Va (FVa) heavy chain peptide VP493 inhibits both FVa activity and activated protein C (APC) inactivation of FVa.
    Heeb, MJ
    Tans, G
    Hoekema, L
    Thomassen, MCLGD
    Kojima, Y
    Rosing, J
    Griffin, JH
    BLOOD, 1995, 86 (10) : 284 - 284
  • [10] AAV-mediated gene transfer for treatment of hemophilia
    Wang, LX
    Herzog, RW
    CURRENT GENE THERAPY, 2005, 5 (03) : 349 - 360
12345